Pieter B. M. W. M. Timmermans
Chief Tech/Sci/R&D Officer at Kosan Biosciences, Inc.
Profile
Pieter B.
M.
W.
M.
Timmermans is a professional with a background in drug discovery and preclinical research.
He is currently employed as the SVP-Drug Discovery & Preclinical Research at Kosan Biosciences, Inc. Prior to this, he held the position of VP-Pharmacology & Preclinical Development at Amgen, Inc. and Tularik, Inc. respectively.
He also worked as an Associate Professor at the University of Amsterdam.
Timmermans received his undergraduate and doctorate degrees from the University of Leiden.
Pieter B. M. W. M. Timmermans active positions
Companies | Position | Start |
---|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | 31/12/2004 |
Former positions of Pieter B. M. W. M. Timmermans
Companies | Position | End |
---|---|---|
AMGEN INC. | Corporate Officer/Principal | 31/12/2004 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 31/12/2003 |
University of Amsterdam | Corporate Officer/Principal | - |
Training of Pieter B. M. W. M. Timmermans
University of Leiden | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
AMGEN INC. | Health Technology |
Private companies | 2 |
---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
- Stock Market
- Insiders
- Pieter B. M. W. M. Timmermans